Acetylcholinesterase Variants in Alzheimer’s Disease: From Neuroprotection to Programmed Cell Death

Publisher： Karger

E-ISSN： 1660-2862|7|1-3|60-63

ISSN： 1660-2854

Source： Neurodegenerative Diseases, Vol.7, Iss.1-3, 2010-02, pp. : 60-63

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

LXR-α genomics programmes neuronal death observed in Alzheimer’s disease

By Raina Ashvinder  

Apoptosis, Vol. 15, Iss. 12, 2010-12 ,pp. : 1461-1469

Springer Publishing Company

Access to resources Recommend Favorite

Evaluation of the Performance of Novel Aβ Isoforms as Theragnostic Markers in Alzheimer’s Disease: From the Cell to the Patient

By  

Neurodegenerative Diseases, Vol. 10, Iss. 1-4, 2012-02 ,pp. : 138-140

Karger

Access to resources Recommend Favorite

Alzheimer’s as a metabolic disease

By Demetrius Lloyd   Driver Jane  

Biogerontology, Vol. 14, Iss. 6, 2013-12 ,pp. : 641-649

Springer Publishing Company

Access to resources Recommend Favorite

Retromers in Alzheimer’s Disease

By  

Neurodegenerative Diseases, Vol. 10, Iss. 1-4, 2012-03 ,pp. : 116-121

Karger

Access to resources Recommend Favorite

Dysregulation of Ca2+ Homeostasis in Alzheimer’s Disease: Role in Acetylcholinesterase Production and AMPA Receptor Internalization

By  

Neurodegenerative Diseases, Vol. 10, Iss. 1-4, 2012-02 ,pp. : 76-79

Karger

Access to resources Recommend Favorite